There was a popular drug for years, revered by doctors and patients as a treatment for certain infectious bacterial infections such as bronchitis, pneumonia and sexually transmitted diseases.
The headlines on azithromycin are not all positive, however. Let's take a peek been busy this antibiotic was:
Z-pack does well worldwide in May
In May, researchers in the UK found that azithromycin improves lung function in patients with bronchiolitis obliterans syndrome (BOS), a life threatening event in most patients after lung transplantation. In fact, BOS is the leading cause of death in a year following a lung transplant.
Last month, azithromycin was prescribed strongly in response to the epidemic of Washington whooping cough (pertussis). Although it is not proven to shorten the duration of illness, it can keep uninfected people to catch.
dark side of Z-pack
Vanderbilt researchers have found that, in rare cases, the "Z-pack" pose a higher risk of cardiovascular mortality in first five days of taking the drug. research shows an increased risk of death, particularly in people with a history of heart problems. the concerns raised by this study are not applicable to children because they are very few risk of heart disease.
so there you have it, folks. this is the story of an antibiotic with a bright future and the not so perfect. We will keep you informed of the next time it drug appears in the news.
0 Komentar